Derik De Bruin analyst

Currently out of the existing stock ratings of Derik De Bruin, 21 are a SELL (16.54%), 54 are a HOLD (42.52%), 52 are a BUY (40.94%).

Derik De Bruin

Work Performance Price Targets & Ratings Chart

Analyst Derik De Bruin, carries an average stock price target met ratio of 72.93% that have a potential upside of 13.47% achieved within 114 days. Previously, Derik De Bruin worked at BAML.

Derik De Bruin’s has documented 259 price targets and ratings displayed on 34 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on DHR, Danaher at 22-Sep-2025.

Wall Street Analyst Derik De Bruin

Analyst best performing recommendations are on TLIS (TALIS BIOMEDICAL CORP).
The best stock recommendation documented was for TLIS (TALIS BIOMEDICAL CORP) at 3/16/2022. The price target of $22.5 was fulfilled within 2 days with a profit of $3 (15.38%) receiving and performance score of 76.92.

Average potential price target upside

ILMN Illumina A Agilent Technologies AVTR Avantor BRKR Bruker DGX Quest Diagnostics DNA Ginkgo Bioworks Holdings GH Guardant Health HOLX Hologic IQV IQVIA Holdings LH Laboratory of America Holdings MTD Mettler-Toledo International MYGN Myriad Genetics PKI PerkinElmer QGEN Qiagen NV SEER Seer  TXG 10X Genomics STVN Stevanato Group SpA TX Ternium SA ADR CTLT Catalent DHR Danaher EXAS EXACT Sciences IDXX IDEXX Laboratories PSNL Personalis TLIS Talis Biomedical Corp WAT Waters WST West Pharmaceutical Services ICLR ICON PLC CRL Charles River Laboratories NEO NeoGenomics ZTS Zoetis TMO Thermo Fisher Scientific FTRE Fortrea Holdings RVTY Revvity PAHC Phibro Animal Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Nov-2023

$150

$5.19 (3.58%)

$130

6 days ago
(26-Jan-2026)

9/25 (36%)

$-0.28 (-0.19%)

78

Buy Since 18-Jan-2022

$155

$10.19 (7.04%)

$200

12 days ago
(20-Jan-2026)

10/17 (58.82%)

$13.35 (9.42%)

134

Sell Since 10-Feb-2025

$110

$-34.81 (-24.04%)

$100

1 months 17 days ago
(15-Dec-2025)

16/19 (84.21%)

$-24.87 (-18.44%)

122

Buy Since 26-Apr-2023

$142

$-2.81 (-1.94%)

$128

3 months 1 days ago
(31-Oct-2025)

5/12 (41.67%)

$18.46 (14.94%)

78

Hold Since 09-Sep-2020

$105

$-39.81 (-27.49%)

$100

5 months 28 days ago
(04-Aug-2025)

6/10 (60%)

$6.56 (6.66%)

157

Show more analysts

Please expand the browser size to see the chart

Which stock is Derik De Bruin is most bullish on?

Potential upside of $16.76 has been obtained for MTD (METTLER-TOLEDO INTERNATIONAL)

Which stock is Derik De Bruin is most reserved on?

Potential downside of -$13.15 has been obtained for PAHC (PHIBRO ANIMAL HEALTH)

What Year was the first public recommendation made by Derik De Bruin?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?